Skip to main content

PATH congratulates Malawi on introducing the first malaria vaccine for African children

The first children have received the RTS,S/AS01 (RTS,S) malaria vaccine through routine immunization in Malawi, marking the beginning of a pilot introduction of the vaccine. Read more......

Research for implementation: Challenges of tracking funding flows highlighted in new report

Pilot survey of funders reveals challenges of tracking money; case studies show potential impact of this research on uptake and usability of drugs, diagnostics, vector control products, and vaccines. Read more...

We’re ready to beat malaria. Are you?

Put your knowledge to the test with a three-question quiz. Ready to begin?

Home

Latest

Long-term incidence of severe malaria following RTS,S/AS01 vaccination in children and infants in Africa: an open-label 3-year extension study of a phase 3 randomized controlled trial

Journal article

RTS,S malaria vaccine implementation in Ghana

RTS,S malaria vaccine implementation in Malawi

The Malaria Vaccine Implementation Programme will reach 360,000 African children per year.

PATH congratulates Malawi on introducing the first malaria vaccine for African children

The RTS,S malaria vaccine

RTS,S malaria vaccine frequently asked questions (FAQs)

ASTMH 67th Annual Meeting

Vials of vaccines in the Bandung BioFarma facility in Indonesia. Photo: PATH.

A new tool for tricky vaccine development

Ninth European & Developing Countries Clinical Trial Partnership (EDCTP) Forum

New report finds $100 million shortfall in annual global investments in malaria research and development

Bridging the gaps in malaria R&D: An analysis of funding—from basic research and product development to research for implementation

World Malaria Congress

Twitter @MalariaVaccine

RT @ProSyn: A new malaria vaccine now being piloted in Sub-Saharan Africa, where 90% of malaria cases occur, could be a game ch… https://t.co/KOrg6hiZ4w

15 Jul 2019

RT @PMIgov: #Malaria is @CDCgov‘s Disease of the Week! 🦟Test your malaria knowledge with this quiz: https://t.co/haPM8CEPa8

12 Jul 2019

Making the Most of the #Malaria #Vaccine by Ifeanyi M. Nsofor @ProSyn https://t.co/9qDQa3bBW5

11 Jul 2019

RT @nothingbutnets: Malaria is the number one infectious disease threat to U.S. troops overseas. In response, the U.S. Department of De… https://t.co/2kNYATdmuK

10 Jul 2019

Learn more about the results of the long-term follow up of the Phase 3 efficacy & safety trial of RTS,S/AS01:… https://t.co/A2cWTDA5oa

10 Jul 2019

Results of a long-term follow up of the Phase 3 efficacy & safety trial of RTS,S/AS01 show strong evidence that the… https://t.co/74aXXS3CX7

10 Jul 2019

RT @GaviSeth: Our new 2021-2025 strategy is all about equity. Our priority is to reach the 1 in 10 children in @Gavi-supported c… https://t.co/STUyYyNlZ4

7 Jul 2019

RT @PAlonsoMalaria: Access to a wealth of #malaria policy guidance just got easier! Our new web pages consolidate all @WHO recommendati… https://t.co/cR8O61N3Ab

5 Jul 2019

RT @MalariaNoMore: Two new studies from @IHME_UW and @MalariaAtlas, published in @TheLancet, present the most comprehensive maps of th… https://t.co/2xPPhJJRrH

5 Jul 2019

RT @ttmalawi: It’s vaccine day today at the Malaria Gordon conference - vaccines that prevent infection and disease and next- gen… https://t.co/XJWbDa4SaV

2 Jul 2019

RT @james_dunlap: Education an important aspect of the phased introduction of the RTS,S #MalariaVaccine. ❤🙏 Awutu Breku in the Efutu… https://t.co/gwGdC2O18O

1 Jul 2019

RT @TheLancet: First high-resolution maps of P vivax clinical burden and prevalence highlight important spatial and temporal patte… https://t.co/k8NoSxjd3X

28 Jun 2019